Women Undergoing CABG More Likely to Get Care at Low-Quality Hospitals

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 29, 2024 -- Female Medicare beneficiaries undergoing coronary artery bypass grafting are more likely to receive care at low-quality hospitals than male beneficiaries, with a greater sex disparity in mortality at low-quality hospitals, according to a study published online June 11 in JAMA Network Open.

Catherine M. Wagner, M.D., and Andrew M. Ibrahim, M.D., from the University of Michigan in Ann Arbor, examined sex disparities in 30-day mortality after coronary artery bypass grafting across high- and low-quality hospitals in a cross-sectional, retrospective cohort study. A total of 444,855 beneficiaries were analyzed (27.1 and 72.9 percent female and male, respectively).

The researchers found that female beneficiaries were more likely to have an unplanned admission than male beneficiaries, and they were more likely to receive care at low- versus high-quality hospitals (odds ratio, 1.26). Risk-adjusted female and male mortality was 4.24 and 2.75 percent, respectively, overall, with an absolute difference of 1.48 percentage points. Male and female mortality was 1.57 and 2.58 percent at the highest-quality hospitals, compared with 4.94 and 7.02 percent at the lowest-quality hospitals (absolute differences, 1.01 and 2.07 percentage points, respectively). More than fourfold higher mortality was seen for female beneficiaries receiving care at low-quality hospitals than male beneficiaries who received care at high-quality hospitals (7.02 versus 1.57 percent).

"Policy aimed at equitable referral of female patients to high-quality centers and targeted improvement of low-quality hospitals may narrow these disparities," the authors write.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-30 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords